Tutorials
Moderna Inc logo

Moderna Inc

$ 186.84 -7.34 (-3.78%) 10:08 PM EST
P/E:
5.69
P/B:
4.07
Market Cap:
$ 73.09B
Enterprise V:
$ 66.08B
Volume:
5.41M
Avg Vol (2M):
5.17M
Also Trade In:
Volume:
5.41M
Market Cap $:
73.09B
PE Ratio:
5.69
Avg Vol (2-Month):
5.17M
Enterprise Value $:
66.08B
PB Ratio:
4.07
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Moderna Inc
NAICS : 325412 SIC : 2836
200 Technology Square, Cambridge, MA, USA, 02139
Description
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Name Current Vs Industry Vs History
Cash-To-Debt 8.9
Equity-to-Asset 0.69
Debt-to-Equity 0.05
Debt-to-EBITDA 0.06
Interest Coverage 744.86
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 9.45
Distress
Grey
Safe
Beneish M-Score 0.48
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 69.44
9-Day RSI 67.48
14-Day RSI 65.36
6-1 Month Momentum % -4.58
12-1 Month Momentum % -62.63

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.99
Quick Ratio 1.71
Cash Ratio 1.16
Days Inventory 123.91
Days Sales Outstanding 46.52
Days Payable 15.17

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -7

Financials (Next Earnings Date:2022-11-04 Est.)

MRNA's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:MRNA

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 22,284
EPS (TTM) ($) 32.81
Beta 1.77
Volatility % 54.97
14-Day RSI 65.36
14-Day ATR ($) 9.904344
20-Day SMA ($) 168.651
12-1 Month Momentum % -62.63
52-Week Range ($) 115.61 - 497.49
Shares Outstanding (Mil) 391.2

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Moderna Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More